Uncategorized

There is new hope for approximately 700,000 people who die each year from antibiotic resistant infections, with University of Queensland researchers discovering how bacteria share antibiotic-resistance genes. UQ’s Professor Mark Schembri said antibiotic resistant bacteria, in particular emerging ‘superbugs’, could lead to around 10 million deaths globally by 2050. “The diminishing pool of effective antibiotics makes these infections a…

The university sector will be vital in the state’s recovery from COVID-19, according to incoming University of Queensland Vice-Chancellor, Professor Deborah Terry. Professor Terry returns to UQ on Monday (3 August) after more than six years serving as Vice-Chancellor and President of Curtin University in Western Australia. Professor Terry said UQ was an incredibly strong…

The next critical phase for The University of Queensland’s COVID-19 vaccine is underway – with the research effort moving out of the lab and into human trials. Healthy adult volunteers have received the first dose of the vaccine at the Brisbane clinic of phase 1 clinical trials specialist, Nucleus Network. UQ vaccine project co-leader Professor…

UQ and CEPI partner with CSL to advance COVID-19 vaccine A landmark partnership will help to accelerate the future development, manufacture and distribution of a University of Queensland COVID-19 vaccine. Key points: Global biotechnology company CSL will further develop, manufacture and distribute UQ’s COVID-19 vaccine candidate. The UQ vaccine is expected to be available in…

The University of Queensland is the only Australian organisation tasked by the Coalition for Epidemic Preparedness Innovations (CEPI) to develop a vaccine against the novel coronavirus. Funding received by government and philanthropic partners is an important extension of CEPI’s ongoing financial support. Donations could help reduce the timeline for an effective vaccine for COVID-19 by six months and advance vaccine…

Researchers have identified a promising new drug combination that could significantly help the immune system target cancer cells and kill them. The study published in Cell, describes a treatment that works by combining an intravenous dosage of a well known anti-nausea drug, prochlorperazine (called Stemetil in Australia), with existing cancer treatments. University of Queensland scientist Associate Professor…